Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: Q4QC10
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 161 | 165 | PF00656 | 0.520 |
CLV_C14_Caspase3-7 | 98 | 102 | PF00656 | 0.656 |
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.568 |
CLV_NRD_NRD_1 | 129 | 131 | PF00675 | 0.491 |
CLV_NRD_NRD_1 | 25 | 27 | PF00675 | 0.468 |
CLV_NRD_NRD_1 | 66 | 68 | PF00675 | 0.433 |
CLV_PCSK_KEX2_1 | 121 | 123 | PF00082 | 0.552 |
CLV_PCSK_KEX2_1 | 27 | 29 | PF00082 | 0.594 |
CLV_PCSK_KEX2_1 | 55 | 57 | PF00082 | 0.544 |
CLV_PCSK_PC1ET2_1 | 121 | 123 | PF00082 | 0.552 |
CLV_PCSK_PC1ET2_1 | 27 | 29 | PF00082 | 0.565 |
CLV_PCSK_PC1ET2_1 | 55 | 57 | PF00082 | 0.544 |
CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.533 |
CLV_PCSK_SKI1_1 | 151 | 155 | PF00082 | 0.597 |
CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.486 |
DEG_APCC_DBOX_1 | 150 | 158 | PF00400 | 0.433 |
DEG_APCC_DBOX_1 | 47 | 55 | PF00400 | 0.365 |
DOC_PP1_RVXF_1 | 29 | 36 | PF00149 | 0.488 |
DOC_PP2B_LxvP_1 | 123 | 126 | PF13499 | 0.539 |
DOC_PP4_FxxP_1 | 59 | 62 | PF00568 | 0.454 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.556 |
DOC_USP7_MATH_1 | 99 | 103 | PF00917 | 0.610 |
DOC_USP7_UBL2_3 | 13 | 17 | PF12436 | 0.576 |
DOC_USP7_UBL2_3 | 132 | 136 | PF12436 | 0.683 |
DOC_USP7_UBL2_3 | 27 | 31 | PF12436 | 0.428 |
DOC_WW_Pin1_4 | 87 | 92 | PF00397 | 0.587 |
LIG_Actin_WH2_2 | 40 | 57 | PF00022 | 0.461 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.659 |
LIG_BRCT_BRCA1_1 | 10 | 14 | PF00533 | 0.590 |
LIG_FHA_1 | 34 | 40 | PF00498 | 0.472 |
LIG_FHA_1 | 88 | 94 | PF00498 | 0.691 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.722 |
LIG_FHA_2 | 114 | 120 | PF00498 | 0.545 |
LIG_SH3_4 | 132 | 139 | PF00018 | 0.549 |
LIG_TRAF2_1 | 86 | 89 | PF00917 | 0.641 |
LIG_WRC_WIRS_1 | 163 | 168 | PF05994 | 0.523 |
MOD_CK2_1 | 113 | 119 | PF00069 | 0.696 |
MOD_GlcNHglycan | 109 | 112 | PF01048 | 0.567 |
MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.595 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.709 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.528 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.557 |
MOD_GSK3_1 | 95 | 102 | PF00069 | 0.595 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.652 |
MOD_PKA_2 | 37 | 43 | PF00069 | 0.538 |
MOD_Plk_2-3 | 101 | 107 | PF00069 | 0.619 |
MOD_Plk_2-3 | 162 | 168 | PF00069 | 0.461 |
MOD_Plk_4 | 162 | 168 | PF00069 | 0.562 |
MOD_ProDKin_1 | 87 | 93 | PF00069 | 0.588 |
MOD_SUMO_for_1 | 86 | 89 | PF00179 | 0.504 |
MOD_SUMO_rev_2 | 118 | 123 | PF00179 | 0.591 |
MOD_SUMO_rev_2 | 77 | 86 | PF00179 | 0.534 |
TRG_DiLeu_BaEn_1 | 66 | 71 | PF01217 | 0.406 |
TRG_ER_diArg_1 | 56 | 59 | PF00400 | 0.537 |
TRG_Pf-PMV_PEXEL_1 | 58 | 63 | PF00026 | 0.521 |
TRG_Pf-PMV_PEXEL_1 | 73 | 77 | PF00026 | 0.355 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NH88 | Trypanosomatidae | 37% | 97% |
A0A3S7WWT3 | Leishmania donovani | 88% | 100% |
A0A422N8U7 | Trypanosoma rangeli | 36% | 98% |
A4HC37 | Leishmania braziliensis | 72% | 100% |
A4HZH9 | Leishmania infantum | 88% | 100% |
D0A0Y3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 82% |
E9AVG9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |